BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1510973)

  • 1. Hepatitis A virus 3C proteinase substrate specificity.
    Jewell DA; Swietnicki W; Dunn BM; Malcolm BA
    Biochemistry; 1992 Sep; 31(34):7862-9. PubMed ID: 1510973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
    Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.
    Schultheiss T; Sommergruber W; Kusov Y; Gauss-Müller V
    J Virol; 1995 Mar; 69(3):1727-33. PubMed ID: 7853510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B.
    Schultheiss T; Kusov YY; Gauss-Müller V
    Virology; 1994 Jan; 198(1):275-81. PubMed ID: 8259663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase.
    Malcolm BA; Lowe C; Shechosky S; McKay RT; Yang CC; Shah VJ; Simon RJ; Vederas JC; Santi DV
    Biochemistry; 1995 Jun; 34(25):8172-9. PubMed ID: 7794931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of synthetic peptide substrates for the poliovirus 3C proteinase.
    Weidner JR; Dunn BM
    Arch Biochem Biophys; 1991 May; 286(2):402-8. PubMed ID: 1654789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of synthetic peptides by purified poliovirus 3C proteinase.
    Pallai PV; Burkhardt F; Skoog M; Schreiner K; Bax P; Cohen KA; Hansen G; Palladino DE; Harris KS; Nicklin MJ
    J Biol Chem; 1989 Jun; 264(17):9738-41. PubMed ID: 2542331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus.
    Petithory JR; Masiarz FR; Kirsch JF; Santi DV; Malcolm BA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11510-4. PubMed ID: 1662396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.
    Cordingley MG; Callahan PL; Sardana VV; Garsky VM; Colonno RJ
    J Biol Chem; 1990 Jun; 265(16):9062-5. PubMed ID: 2160953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity studies on retroviral proteinase from myeloblastosis-associated virus.
    Strop P; Konvalinka J; Stys D; Pavlickova L; Blaha I; Velek J; Travnicek M; Kostka V; Sedlacek J
    Biochemistry; 1991 Apr; 30(14):3437-43. PubMed ID: 1849425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of recombinant hepatitis A virus 3C proteinase.
    Malcolm BA; Chin SM; Jewell DA; Stratton-Thomas JR; Thudium KB; Ralston R; Rosenberg S
    Biochemistry; 1992 Apr; 31(13):3358-63. PubMed ID: 1313294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A.
    Sommergruber W; Ahorn H; Zöphel A; Maurer-Fogy I; Fessl F; Schnorrenberg G; Liebig HD; Blaas D; Kuechler E; Skern T
    J Biol Chem; 1992 Nov; 267(31):22639-44. PubMed ID: 1331062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition.
    Bergmann EM; Mosimann SC; Chernaia MM; Malcolm BA; James MN
    J Virol; 1997 Mar; 71(3):2436-48. PubMed ID: 9032381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.
    Bergmann EM; Cherney MM; Mckendrick J; Frormann S; Luo C; Malcolm BA; Vederas JC; James MN
    Virology; 1999 Dec; 265(1):153-63. PubMed ID: 10603326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis.
    Cohen L; Bénichou D; Martin A
    J Virol; 2002 Aug; 76(15):7495-505. PubMed ID: 12097562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase.
    Davis GJ; Wang QM; Cox GA; Johnson RB; Wakulchik M; Dotson CA; Villarreal EC
    Arch Biochem Biophys; 1997 Oct; 346(1):125-30. PubMed ID: 9328292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further requirements for cleavage by the murine coronavirus 3C-like proteinase: identification of a cleavage site within ORF1b.
    Piñón JD; Teng H; Weiss SR
    Virology; 1999 Oct; 263(2):471-84. PubMed ID: 10544119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.